ResMD’s enterprise image and document viewing solution provides one simple interface for healthcare professionals across the globe to securely access patient imaging. John W. Ayers, Ph.D., is deputy director of informatics in Altman Clinical and Translational Research Institute and a Qualcomm Institute affiliate at University of California, San Diego. Image courtesy of Qualcomm Institute at UC San Diego

John W. Ayers, Ph.D., is deputy director of informatics in Altman Clinical and Translational Research Institute and a Qualcomm Institute affiliate at University of California, San Diego. Image courtesy of Qualcomm Institute at UC San Diego 


February 1, 2024 — Banyan Software, a leading acquirer and permanent home for great software businesses, announces the acquisition of ResolutionMD (“ResMD”) from Calgary Scientific, Inc. ResMD is an industry leading medical imaging visualization platform that empowers healthcare professionals to collaborate and diagnose patients while viewing and sharing 2D and 3D medical images. 

ResMD’s enterprise image and document viewing solution provides one simple interface for healthcare professionals across the globe to securely access patient imaging. The platform integrates with all major EHR/EMR vendors, providing secure and direct access to patient image data anywhere, and on any device. 

Chris Slaymaker, the current General Manager who brings over eight years experience within the company, will become the new CEO. 

“We’re thrilled to welcome the ResMD team to the Banyan family. They will be a core part of our healthcare portfolio and also an exciting platform to grow within radiology. Our team is committed to facilitating a seamless integration and investing in the resources necessary to build upon their success. The goal remains the same: enhance patient care and streamline healthcare workflows through innovative imaging technology,” stated Darren Harris, operating partner, Banyan Software. 

“I’m looking forward to this next phase of growth for the business. The opportunity to leverage the expertise and resources that comes with being part of a larger family of businesses is unique and enticing. The buy-and-hold for life model and the decentralized management approach means our team and customers will continue to be well supported long into the future,” said Chris Slaymaker, general manager, ResolutionMD. 

For more information: www.banyansoftware.com 


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | HIMSS

February 29, 2024 — The Healthcare Information Management Systems Society, HIMSS, recently announced it HIMSS 2024 ...

Time February 29, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 28, 2024 — DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto ...

Time February 28, 2024
arrow
News | Radiology Business

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
Subscribe Now